UK Markets close in 3 hrs 14 mins

Abeona Therapeutics Inc. (0H7R.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
0.1803+0.0123 (+7.32%)
As of 04:51PM BST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.34
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 30.2249
52-week low 30.1803
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 547.94M
Implied shares outstanding 6N/A
Float 8124.15M
% held by insiders 110.53%
% held by institutions 123.67%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)31 Dec 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,912.33%

Management effectiveness

Return on assets (ttm)-31.07%
Return on equity (ttm)-110.36%

Income statement

Revenue (ttm)3M
Revenue per share (ttm)0.03
Quarterly revenue growth (yoy)0.00%
Gross profit (ttm)-299k
EBITDA -54.12M
Net income avi to common (ttm)-84.94M
Diluted EPS (ttm)-0.5670
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)45.02M
Total cash per share (mrq)0.31
Total debt (mrq)9.38M
Total debt/equity (mrq)18.25
Current ratio (mrq)3.33
Book value per share (mrq)0.78

Cash flow statement

Operating cash flow (ttm)-65.67M
Levered free cash flow (ttm)-61.7M